A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides

Completed · Phase 3 · Has a placebo group

Conditions studied: Facial Rhytides, Glabellar Rhytides

In brief

This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial rhytides (forehead lines, glabellar lines, lateral canthal lines \[crow's feet lines\]).

Key facts

Study ID
NCT02261493
Run by
Allergan
People needed
787
Starts
2014-10-27
Expected to finish
2016-04-20
Last updated by the study team
2017-07-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.